Small Molecule Drugs in Inflammatory Bowel Diseases.
Crohn’s disease
inflammatory bowel diseases
small molecule drugs
ulcerative colitis
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
30 Jun 2021
30 Jun 2021
Historique:
received:
18
05
2021
revised:
23
06
2021
accepted:
24
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Inflammatory bowel diseases (IBDs), mainly represented by Crohn's disease (CD) and Ulcerative Colitis (UC), are chronic disorders with an unclear pathogenesis. This incurable and iterative intestinal mucosal inflammation requires the life-long use of anti-inflammatory drugs to prevent flares or relapses, which are the major providers of complications, such as small bowel strictures and intestinal perforations. The introduction of tumor necrosis factor (TNF)-alpha inhibitors and other compounds, such as anti-IL12/23 and anti-alpha4/beta7 integrin monoclonal antibodies, has considerably improved the clinical management of IBDs. They are now the standard of care, being the first-line therapy in patients with aggressive disease and in patients with moderate to severe disease with an inadequate response to conventional therapy. However, for approximately one third of all patients, their efficacy remains insufficient by a lack or loss of response due to the formation of anti-drug antibodies or compliance difficulties with parenteral formulations. To address these issues, orally administered Small Molecules Drugs (SMDs) that use a broad range of novel pharmacological pathways, such as JAK inhibitors, sphingosine-1-phosphate receptor modulators, and phosphodiesterase 4 inhibitors, have been developed for CD and UC. This article provides an updated and complete review of the most recently authorized SMDs and SMDs in phase II/III development.
Identifiants
pubmed: 34209234
pii: ph14070637
doi: 10.3390/ph14070637
pmc: PMC8308576
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Clin Pharmacol Drug Dev. 2021 May 4;:
pubmed: 33942566
Cochrane Database Syst Rev. 2018 Aug 01;8:CD006097
pubmed: 30068022
J Crohns Colitis. 2021 Jul 5;15(7):1120-1129
pubmed: 33438008
Autoimmun Rev. 2017 May;16(5):495-503
pubmed: 28279838
J Crohns Colitis. 2021 Jun 22;15(6):938-949
pubmed: 33599720
Mult Scler Relat Disord. 2020 Aug;43:102129
pubmed: 32428844
Inflamm Bowel Dis. 2020 Mar 4;26(4):643-652
pubmed: 31077582
Stem Cell Reports. 2018 Jan 9;10(1):17-26
pubmed: 29276155
Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):605-616
pubmed: 28537216
Inflamm Bowel Dis. 2020 Dec 16;:
pubmed: 33324993
Clin Pharmacol Drug Dev. 2021 Mar;10(3):229-240
pubmed: 33513294
Aliment Pharmacol Ther. 2019 Nov;50(10):1068-1076
pubmed: 31599001
Medicina (Kaunas). 2020 Jan 20;56(1):
pubmed: 31968710
Clin Rheumatol. 2020 Oct;39(10):2919-2930
pubmed: 32303858
Ann Rheum Dis. 2016 Jun;75(6):1057-64
pubmed: 26672064
Lancet. 2017 Jul 8;390(10090):135-144
pubmed: 28527704
Am J Gastroenterol. 2020 May;115(5):738-745
pubmed: 31850931
N Engl J Med. 2015 Mar 19;372(12):1104-13
pubmed: 25785968
J Inflamm Res. 2020 Sep 14;13:519-531
pubmed: 32982367
Clin Gastroenterol Hepatol. 2019 Jan;17(1):139-147
pubmed: 30012431
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):819-828
pubmed: 32553149
Drug Metab Dispos. 2014 Apr;42(4):759-73
pubmed: 24464803
J Clin Gastroenterol. 2016 Nov/Dec;50(10):803-818
pubmed: 27741097
J Crohns Colitis. 2021 Jun 22;15(6):950-959
pubmed: 33475734
Gastroenterology. 2006 Dec;131(6):1786-98
pubmed: 17087939
Clin Transl Gastroenterol. 2016 Jan 07;7:e135
pubmed: 26741065
N Engl J Med. 2018 Oct 4;379(14):1313-1321
pubmed: 30205746
Gastroenterology. 2007 Jan;132(1):76-86
pubmed: 17241861
N Engl J Med. 2017 May 4;376(18):1723-1736
pubmed: 28467869
J Crohns Colitis. 2016 May;10(5):549-55
pubmed: 26738757
Inflamm Bowel Dis. 2019 Jan 10;25(2):270-282
pubmed: 30165490
Expert Opin Investig Drugs. 2018 Jul;27(7):623-629
pubmed: 29985060
Lancet. 2007 May 12;369(9573):1641-57
pubmed: 17499606
J Crohns Colitis. 2018 Nov 9;12(10):1158-1169
pubmed: 29917064
Mucosal Immunol. 2008 Nov;1 Suppl 1:S50-3
pubmed: 19079231
Ann Rheum Dis. 2020 Nov;79(11):1400-1413
pubmed: 32759265
Gastroenterology. 2020 Jun;158(8):2123-2138.e8
pubmed: 32044319
Gastroenterology. 2005 Aug;129(2):550-64
pubmed: 16083712
Dig Dis Sci. 2021 Aug;66(8):2732-2743
pubmed: 32816215
Pharmacol Res. 2013 Oct;76:1-8
pubmed: 23827161
Aliment Pharmacol Ther. 2019 Feb;49(3):265-276
pubmed: 30663107
Int J Mol Sci. 2017 Jun 15;18(6):
pubmed: 28617319
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95
pubmed: 23835489
Biomol Ther (Seoul). 2017 Jan 1;25(1):80-90
pubmed: 28035084
Eur J Drug Metab Pharmacokinet. 2020 Oct;45(5):557-573
pubmed: 32361977
Clin Gastroenterol Hepatol. 2019 Jul;17(8):1541-1550
pubmed: 30476584
Gastroenterology. 2020 Feb;158(3):550-561
pubmed: 31711921
Gastroenterology. 2020 Jun;158(8):2139-2149.e14
pubmed: 32092309
Gut. 2019 Dec;68(Suppl 3):s1-s106
pubmed: 31562236
Clin Gastroenterol Hepatol. 2020 Oct;18(11):2526-2534.e9
pubmed: 31926340
Gut. 2017 Jun;66(6):1049-1059
pubmed: 28209624
Eur J Gastroenterol Hepatol. 2020 Jun;32(6):669-677
pubmed: 32282548
Gastroenterology. 2021 Jun;160(7):2595-2598.e3
pubmed: 33662385
Sci Rep. 2019 Jan 28;9(1):792
pubmed: 30692590
Prog Med Chem. 2013;52:153-223
pubmed: 23384668
Clin Exp Gastroenterol. 2009;2:101-9
pubmed: 21694833
BMC Gastroenterol. 2015 Feb 05;15:14
pubmed: 25651782
Am J Physiol Gastrointest Liver Physiol. 2016 Feb 1;310(3):G155-62
pubmed: 26608188
Gut. 2019 Apr;68(4):604-614
pubmed: 29618496
Pharmacoeconomics. 2020 Dec;38(12):1345-1358
pubmed: 32929677
N Engl J Med. 2016 May 5;374(18):1754-62
pubmed: 27144850
N Engl J Med. 2013 Aug 22;369(8):754-62
pubmed: 23964937
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30
pubmed: 31648971
Lancet. 2017 Jan 21;389(10066):266-275
pubmed: 27988142
Aliment Pharmacol Ther. 2020 Jan;51(2):271-280
pubmed: 31660640
Clin Pharmacokinet. 2018 Aug;57(8):977-988
pubmed: 29076110
Lancet. 2018 Dec 23;390(10114):2769-2778
pubmed: 29050646
Clin Pharmacokinet. 2015 Aug;54(8):859-74
pubmed: 25681059
World J Gastroenterol. 2018 May 7;24(17):1868-1880
pubmed: 29740202
Gut. 2018 Oct;67(10):1824-1835
pubmed: 28982740
Nat Rev Drug Discov. 2017 Dec;16(12):843-862
pubmed: 29104284
Clin Gastroenterol Hepatol. 2018 Sep;16(9):1374-1384
pubmed: 29481970
Drugs R D. 2019 Dec;19(4):351-366
pubmed: 31621054
Gastroenterology. 2011 May;140(6):1827-1837.e2
pubmed: 21530749
Gut Liver. 2019 Nov 15;13(6):604-616
pubmed: 31195433
Br J Pharmacol. 2016 Jun;173(11):1778-92
pubmed: 26990079
Ann Gastroenterol. 2018 Jul-Aug;31(4):413-424
pubmed: 29991886